ARK Genomic Revolution ETF Rating $23.36 +0.10 (+0.43%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.70Holdings in ARKG have an aggregate rating of Moderate Buy based on 457 analyst ratings issued in the past year covering 36 companies (99.9% of the portfolio).ARKG Aggregate Price Target$23.36High Prediction$23.36Average Prediction$23.36Low Prediction$23.36Holdings in ARKG have an aggregate price target of $23.36 and a range of $23.36 to $23.36 covering 36 companies (99.9% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 36 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.37%TWSTTwist Bioscience$41.11-0.5%4.1398 of 5 stars2.67$51.78 25.9%9Analyst ForecastAnalyst RevisionNews Coverage7.42%RXRXRecursion Pharmaceuticals$6.04-3.7%1.9971 of 5 stars2.40$9.25 53.1%5Analyst ForecastOptions VolumeHigh Trading Volume7.34%CRSPCRISPR Therapeutics$47.26+0.6%1.771 of 5 stars2.37$74.94 58.6%195.03%ADPTAdaptive Biotechnologies$4.42-1.3%4.3927 of 5 stars2.75$6.50 47.1%4Short Interest ↓Analyst Revision4.77%CDNACareDx$22.37+1.4%3.8886 of 5 stars2.43$29.60 32.3%74.51%VCYTVeracyte$39.20+0.1%4.1264 of 5 stars2.78$41.25 5.2%9Analyst Forecast4.26%TEMTempus AI$58.15+7.7%0.7353 of 5 stars2.70$54.22 -6.8%10Gap Up4.14%SDGRSchrödinger$19.17+1.3%2.0033 of 5 stars2.82$32.90 71.6%114.01%BEAMBeam Therapeutics$24.49-3.2%2.9285 of 5 stars2.75$44.91 83.4%123.89%NTLAIntellia Therapeutics$13.12-7.1%4.5389 of 5 stars2.72$54.94 318.7%18Analyst ForecastAnalyst Revision3.85%IONSIonis Pharmaceuticals$35.40+4.9%4.2328 of 5 stars2.68$60.65 71.3%193.82%NTRANatera$167.88+3.6%2.8052 of 5 stars3.00$140.59 -16.3%17Analyst Forecast3.78%NRIXNurix Therapeutics$22.64-0.7%2.7301 of 5 stars2.93$29.40 29.9%153.56%TXG10x Genomics$13.32-1.8%4.6868 of 5 stars2.53$29.19 119.1%173.49%GHGuardant Health$30.684.2853 of 5 stars2.94$40.60 32.3%163.19%ARCTArcturus Therapeutics$16.17-10.5%2.0686 of 5 stars3.13$71.40 341.6%82.70%PSNLPersonalis$3.46-6.2%4.2117 of 5 stars3.00$6.81 96.9%42.19%ABSIAbsci$2.68-1.5%1.4611 of 5 stars3.00$8.67 223.4%62.16%PACBPacific Biosciences of California$1.721.5162 of 5 stars2.47$3.63 110.8%15Analyst Revision1.71%BFLYButterfly Network$3.33+9.2%1.179 of 5 stars3.00$3.00 -9.8%11.70%VEEVVeeva Systems$210.63+0.4%4.7385 of 5 stars2.58$236.92 12.5%24Analyst Forecast1.68%AMGNAmgen$287.87+2.8%4.9084 of 5 stars2.46$333.57 15.9%26Ex-DividendShort Interest ↓1.47%ACCDAccolade$3.56+2.0%4.8396 of 5 stars2.80$9.04 154.0%15Short Interest ↓1.29%VRTXVertex Pharmaceuticals$451.23+0.7%4.0527 of 5 stars2.53$499.12 10.6%30Analyst DowngradeNews CoveragePositive News1.25%ILMNIllumina$131.68-2.5%4.5866 of 5 stars2.67$164.00 24.5%24Positive News1.18%CERSCerus$1.66-1.2%2.6525 of 5 stars2.75$3.63 118.4%4Positive News1.11%INCYIncyte$71.05+0.7%3.9 of 5 stars2.38$77.16 8.6%21Analyst Forecast0.92%REGNRegeneron Pharmaceuticals$743.35-0.2%4.7877 of 5 stars2.78$1,099.55 47.9%230.90%PRMEPrime Medicine$2.99-5.7%3.0735 of 5 stars2.89$13.25 343.1%9Analyst Revision0.81%LABStandard BioTools$1.61+6.6%3.2166 of 5 stars3.00$2.88 78.6%20.75%CMPSCOMPASS Pathways$4.66-2.1%2.8558 of 5 stars3.00$30.67 558.1%7Short Interest ↓0.69%MASS908 Devices$2.56+3.2%2.772 of 5 stars2.50$8.00 212.5%40.68%QSIQuantum-Si$1.39+120.6%2.5603 of 5 stars2.50$2.50 79.9%2Options VolumeAnalyst RevisionNews CoverageGap UpHigh Trading Volume0.65%EXASExact Sciences$52.70-2.3%4.8868 of 5 stars2.95$74.47 41.3%19Positive News0.64%RPTXRepare Therapeutics$2.84-1.4%2.672 of 5 stars3.33$10.00 252.1%30.01%MRNAModerna$36.94-0.9%4.6286 of 5 stars2.18$84.00 127.4%22Analyst UpgradeAnalyst Revision This page (BATS:ARKG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts